abiraterone,olaparib
astrazeneca,janssen,merck
['abira', 'abiraterone', 'biomarker', 'propel', 'olaparib', 'crpc', 'marker ']
biomarker analysis and updated results from the phase iii #propel trial of abiraterone and olaparib vs abiraterone and pbo as 1l therapy for patients with #mcrpc. presented by fred saad, md, frcs . #esmo22 coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology